Figure 1. Contrast-enhanced computed tomographic images (A-C, and G-I) and 18F-fluorodeoxyglucose positron-emission tomography/computed tomographic images (D-F, and J-L) before and after nivolumab plus ipilimumab treatment. Red and yellow arrowheads indicate disease lesions.